← All trials
NCT02059681
Phase 1Interventional
Includes initial studies to determine the metabolism and pharmacologic actions of drugs in humans, the side effects associated with increasing doses, and to gain early evidence of effectiveness; may include healthy participants and/or patients.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Dec 31, 2013
- Primary completion
- Feb 28, 2022
- Completion date
- Feb 28, 2022
- First posted
- Feb 11, 2014
- Last posted
- Mar 22, 2022
- Enrollment
- 12
- Arms / groups
- 1 / —
- Source
- AACT · ctgov ingestion
Sponsors
- University of TurinCollaborator
- Azienda Ospedaliera San Gerardo di MonzaCollaborator
- Azienda Sanitaria Ospedaliera Molinette S. Giovanni BattistaCollaborator
- Centro Cardiologico Monzino IRCCSOfficial
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.